Form D · Biotechnology
VCENNA, Inc
Mountain View, CA · CIK 0001906200
Offering snapshot reported Jan 21, 2022 · SEC filing
- Reported sold
- $250K Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jan 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 21, 2022 | Initial | $250,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-430439
Simple Agreement for Future Equity (SAFE note)
Source: Form D, filed Jan 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Seyed Reza Etminan | Executive |
| Jonathan Lu | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
108 Berry Court
Mountain View, CA, 94043
Mountain View, CA, 94043